Navigation Links
Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
Date:2/10/2009

SEATTLE, Feb. 10 /PRNewswire-FirstCall/ -- Cell Therapeutics (CTI) (NASDAQ and MTA: CTIC) today announced that they have executed a definitive collaborative agreement with IDIS to manage its investigational drug pixantrone on a named patient basis in Europe. Pixantrone will be supplied by IDIS to healthcare professionals for the treatment of individual patients with relapsing aggressive non-Hodgkin's lymphoma. This program is expected to be initiated by second quarter of 2009.

"Under the named patient program, CTI will be able to provide pixantrone to European patients in need at the prescriber's request while moving it through the approval process in the United States," noted Craig Philips, President of CTI. "With the announcement of preliminary results showing significantly higher rate of complete remission and improvement in progression-free survival for patients receiving pixantrone compared to standard chemotherapeutic agents, we expect to receive a number of requests for pixantrone to treat specific patients."

"Pixantrone is an important new treatment with impressive remission and progression-free survival data," said Dr. Raul Herbrecht of Strasbourg University Hospital in France. "This drug is also important because it meets an unmet medical need for this group of patients. I have been impressed by the good tolerance and efficacy of pixantrone since the first clinical trial we had with this drug in our department. We obtained excellent results in salvage therapy of non-Hodgkin's lymphoma in heavily pretreated patients and several years later some of our patients are still in complete response. These positive results have been confirmed in further studies," Dr Herbrecht added.

The EXTEND clinical trial was a phase III single-agent trial of pixantrone for patients with relapsed, aggressive non-Hodgkin's lymphoma who received two or more prior therapies and who were sensitive to treatment with anthra
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
2. PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy
3. DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
4. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
5. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
6. Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
7. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
8. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
9. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
10. Cara Therapeutics Initiates Phase II Proof-Of-Concept Trial of Novel Analgesic in Acute Post-Operative Pain
11. ExonHit Therapeutics Expands Strategic Collaboration With Allergan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015  Boston Children,s ... benefiting from 3D printing of their anatomy before ... life-threatening cerebrovascular malformations (abnormalities in the brain,s blood ... Reporting online today in the Journal of ... of 3D printing and synthetic resins to create ...
(Date:7/31/2015)... Inc. (Nasdaq: SMLR ), a company that provides ... groups, today reported financial results for the second quarter ... second quarter of 2015, Semler reported continued progress with ... quarter revenue growth of 8%, and quarter over quarter ... 18%," said Doug Murphy-Chutorian, M.D., chief executive officer of ...
(Date:7/30/2015)... , July 30, 2015 Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, today announced that Robert ... Directors. "Bob is an ardent champion for innovation ... privilege to have him on Edwards, board as we pursue ... Edwards, chairman and CEO.  "Bob has provided a valuable perspective ...
Breaking Medicine Technology:3D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6
... SPRING, Md., May 13, 2011  The following was ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Fast Facts ... use products marketed as dietary supplements that also claim ... illegal products are falsely promoted with claims to treat ...
... 13, 2011 Amgen (NASDAQ: AMGN ) will ... (AUA) Conference on Tuesday, May 17 at 12:00 p.m. Eastern ... clinical investigator will participate at the meeting to discuss data ... the conference call will be simultaneously broadcast over the Internet ...
Cached Medicine Technology:FDA: Don't Buy Drugs Marketed as Antimicrobial Dietary Supplements 2FDA: Don't Buy Drugs Marketed as Antimicrobial Dietary Supplements 3FDA: Don't Buy Drugs Marketed as Antimicrobial Dietary Supplements 4Amgen to Webcast Investor Meeting at Upcoming American Urological Association Conference 2
(Date:7/31/2015)... Atlanta, GA (PRWEB) , ... July 31, 2015 ... ... Medicine Practice, Pediatric Emergency Medicine Practice, and Hospital Medicine Practice, is pleased to ... Practice in a mobile application format available on iPhones, iPads, and Android ...
(Date:7/31/2015)... ... 31, 2015 , ... A family-run business in Grand Rapids, ... sourced all over the world, then manufactured into specific formulations in northern Michigan. ... highest-quality oils in the industry, which we are bringing to consumers at prices ...
(Date:7/31/2015)... ... July 31, 2015 , ... An ... from NBC talked about a woman’s unfortunate experience having cosmetic skin procedures done ... face, which resulted in blistering, swelling, bruising, and pain. This woman’s experience is ...
(Date:7/31/2015)... ... ... Super-Sod wants to participate in planning new home lawns from the ground ... fit for such a goal. Houzz is a social media site that features home ... that spreads home and home garden design ideas when members share their project pictures ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... distribution of a wide variety of nutritional and wellness products, announced the addition ... that specializes in massage therapy, active isolated stretching and the prevention and rehabilitation ...
Breaking Medicine News(10 mins):Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 2Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 3Health News:Living Pure Essential Oils takes Therepeutic Essential Oil Market by Storm 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 3Health News:Super-Sod Created a Landscape Profile on Houzz.com for Home Garden Design 2Health News:NPI Welcomes Vincent Aquilino to Board of Directors 2
... Sales and Pro Forma EPS Guidance, BETHESDA, Md., July ... net sales of $181.2 million for the,quarter ended June 30, ... year,s comparable quarter. Net income increased by $2.9 million, or,57.2%, ... million in same,quarter last year., Pro forma net income ...
... International and,Elanco today announced that they have signed ... hunger organization. Elanco is,an animal health company headquartered ... around the world. Elanco makes veterinary medicines,and products ... partnership will engage the unique talents of Elanco,s ...
... suggests brain needs ,experience replay, during slumber , , TUESDAY, ... of memories during sleep, a process that,s crucial for ... University of Arizona researchers. , The researchers recorded ... in learning and memory -- in 11 young and ...
... announced today that Craig M. Walker, M.D., has been ... of directors from,four to five. Dr. Walker brings over ... investigator and thought leader., "Dr. Walker will be ... the,world,s leading experts in the care of patients with ...
... H.R. 1108 Allows FDA Un-Precedential Regulatory Authority Over ... largest,Hispanic faith-based organization in the country, presses Congress ... and pass H.R 1108, "The,Family Smoking Prevention and ... ability to regulate tobacco products and marketing in ...
... Calif., July 29 Align,Technology, Inc. (Nasdaq: ... its,Invisalign product family: Invisalign Teen for non-adult, comprehensive,orthodontic ... that meet their desire for aesthetic treatment and ... of sports, music and,other activities. According to consumer ...
Cached Medicine News:Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 2Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 3Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 4Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 5Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 6Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 7Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 8Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 9Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 10Health News:Heifer and Elanco Announce Charitable Partnership 2Health News:Aging Hinders Memory Storage During Sleep 2Health News:VASAMED(R) Appoints Craig M. Walker, MD to Board of Directors 2Health News:Align Technology Targets Mainstream Orthodontics Market With Invisalign Teen(TM) 2Health News:Align Technology Targets Mainstream Orthodontics Market With Invisalign Teen(TM) 3Health News:Align Technology Targets Mainstream Orthodontics Market With Invisalign Teen(TM) 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: